Enterprise Value to EBITDA Multiple ratio Analysis of Pliant Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-4320.87
Period Ending - Dec-22
Very Poor EV to EBITDA
-3.85
Growth
-112257.45 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-3.39
EV to EBITDA Analysis of Pliant Therapeutics Inc
| EV to EBITDA Ratio of PLRX drastically fell by -112257.45 % this year. |
| EV to EBITDA Ratio with value of 205.61 was highest in Year Dec-19 in last Five Years. |
| EV to EBITDA Ratio with value of -4320.87 was lowest in Year Dec-23 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -4320.87 is lower than Average EV to EBITDA of -825.50 in last five years. |
Other EV to EBITDA Related Info of PLRX that may interest you.
Pliant Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| PLRX | 11.2 | 11.8 | 5.08 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Pliant Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | -4320.87 | -3.85 | -3.70 | -4.68 | 205.61 | -4.19 | 0 |
| Change | -112257.45 % | -3.83 % | 20.83 % | -102.28 % | 5011.29 % |
FY Chart of Enterprise Value to EBITDA Multiple of Pliant Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)